Neurological profile and neurodevelopment of 88 children infected with HIV and 84 seroreverter children followed from 1995 to 2002

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 5, 2006, Pages 322-326

  Tahan, Tony Tannous ^a,b   Bruck, Isac ^a   Burger, Marion ^a   Cruz, Cristina Rodriques ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

CAT CLAMS; DENVER I; DENVER II; HIV infected children; HIV seroverter children; Neurodevelopment

Indexed keywords

APATHY; ARTICLE; BRAIN DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEVELOPMENTAL STAGE; FAHR DISEASE; HEMIPLEGIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERACTIVITY; INFANT; LANGUAGE DISABILITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; OUTPATIENT; PRESCHOOL CHILD; PREVALENCE; SCORING SYSTEM; SCREENING TEST; SPASTICITY; VALIDATION PROCESS;

AIDS DEMENTIA COMPLEX; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DEVELOPMENTAL DISABILITIES; FEMALE; HIV SERONEGATIVITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33947383344     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702006000500004     Document Type: Article

References (24)

1. Magalhães A. A., Chiarada M. V. Recém-nascido de mãe HIV+. Pediatria Moderna 2000;36(3):110-8.
2. Bruck I., Tahan T.T., Cruz C.R. et al. Developmental milestones of vertically HIV infected and seroreverter children. Arq. Neuropsiquiatr 2001;59(3B):691-5.
3. Belman A.L. Aquired immunodeficiency syndrome and the child's central nervous system. Pediatr Clin Am 1992;39:691-714.
4. Tardieu M. HIV-1 and the developing central nervous system. Dev Med Child Neurol 1998;40:843-6.
5. Chase C., Vibbert M., Pelton S.I., et al. Early neurodevelopmental growth in children with vertically transmitted human immunodeficiency virus infection. Arch Pediatr Adolesc Med 1995;149:850-5.
6. Belman A.L., Ultmann M.H., Houropian D. Neurological complications in infants and children with acquired immune deficiency. Ann Neurol 1985;18:560-6.
7. Epstein L.G., Sharer L.R., Joshi V.V., et al. Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol 1985;17:488-96.
8. Nellhaus G. Head circumference from birth to eighteen years. Pediatrics 1968;41:106.
9. Capute A.J., Shapiro B.K., Wachtel R.C., et al. The Clinical Linguistic and Auditory Milestone Scale (CLAMS) Identification of cognitive defects in motor-delayed children. AJCD 1986;140:694-8.
10. Rossman M.J., Hyman S.L., Rorabaugh M.L., et al. The CAT/CLAMS assessment for early intervention services. Clin Pediatr 1994;33:404-9.
11. Wachtel R.C., Shapiro B.K., Palmer B.F., et al. Cat/Clams: A Tool For The Pediatric evaluation of infants and young children with developmental delay. Clin Pediatr 1994a;33:410-5.
12. Capute A.J., Accardo P.J. The infant neurodevelopmental clinical interpretive manual for CAT-CLAMS in the first two years of life. Part 1. Curr. Probl. Pediatr 1996;26:238-56.
13. Kube D.A., Wilson W.M., Petersen M.C., Palmer F.B. CAT/CLAMS: its use in detecting early childhood cognitive impairment. Pediatr Neurol 2000;23:208-15.
14. Pittock S.T., Juhn Y.J., Adegbenro A., Voigt R.G. Ease of administration of the cognitive adaptive test/clinical linguistic and auditory milestone scale (CAT/CLAMS) during pediatric well-child visits. Clin Pediatr (Phila) 2002;41:397-403.
15. Frankenburg W.K., Doods J.B. The Denver Developmental Screening Test. Pediatrics 1967;71:181-91.
16. Frankenburg W.K., Dodds J., Archer P., et al. The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics 1991;90(3):477-9.
17. Glascoe F.P., Byrne K.E., Ashford L.G., et al. Accuracy of the Denver-II in developmental screening. Pediatrics 1992;89:1221-5.
18. Sciarillo W.G., Brown M.M., Robinson N.M., et al. Effectiveness of the Denver Developmental Screening Test with biologically vulnerable infants. J Dev Behav Pediatr 1986;7:77-83.
19. Chang Y.C., Huang C.C., Hu S.C. Establishing the norm of Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/ CLAMS) in Chinese infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, Set-Out, 1998;39(5):306-13.
20. Belman A.L., Muenz L.R., Marcus J.C., et al. Neurologic status of human immunodeficiency virus 1-infected infants and their controls: A prospective study from birth to 2 years. Mothers and infants cohort study. Pediatrics 1996;98:1109-18.
21. Angelini L., Zibordi F., Triulzi F., et al. Age-dependent neurologic manifestations of HIV infection in childhood. Neurolog Sci 2000;21(3):135-42.
22. Bossi G., Maccabruni A., Caselli D., et al. Neurological manifestation in HIV - infected child. Minerva Pediatr 1995;47(7-8):285-95.
23. Carli C., Civitello L.A., Brouwers P., Pizzo P. A. The prevalence of Computed Tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann Neurol 1993;34:198-205.
24. Price D.B., Inglese C.M., Jacobs J., et al. Pediatr Radiol 1988;18(6):445-8.